AAFP NRN Study Sheds Light on Asthma Treatment in Black Adults
A recent study examined treatment options for black adults with asthma, finding no difference between adding tiotropium or a long-acting beta agonist to inhaled corticosteroids. (Source: AAFP News)
Source: AAFP News - February 2, 2016 Category: Primary Care Source Type: news
Tiotropium/olodaterol in COPD: Disadvantages in some patients, advantages in others
(Institute for Quality and Efficiency in Health Care) For most patients, the fixed-dose combination has neither advantages nor disadvantages. More flare-ups occur in higher severity grades. Women with rare flare-ups have advantages. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 20, 2015 Category: Global & Universal Source Type: news
Asthma: No Clear Winners in Combination Treatment in Blacks Asthma: No Clear Winners in Combination Treatment in Blacks
A randomized trial showed no benefit to long-acting beta-agonists over tiotropium in combination with inhaled corticosteroid for improving outcomes in black adults with asthma. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 18, 2015 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
Asthma: LABA + Steroids Not a Winning Combo for Blacks
(MedPage Today) -- Tiotropium is just as good as steroid add-on and perhaps safer (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - October 27, 2015 Category: Respiratory Medicine Source Type: news
Spiriva Respimat (Tiotropium Bromide Inhalation Spray) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 2, 2015 Category: Drugs & Pharmacology Source Type: news
Spiriva Respimat (Tiotropium) Gets Asthma Indication in USSpiriva Respimat (Tiotropium) Gets Asthma Indication in US
The FDA approved a once-daily dose, delivered in two puffs, for long-term maintenance treatment of asthma in people aged 12 years and older. FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 16, 2015 Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news
Tiotropium (Spiriva Respimat) Gets Asthma Indication in USTiotropium (Spiriva Respimat) Gets Asthma Indication in US
The FDA approved a once-daily dose, delivered in two puffs, for long-term maintenance treatment of asthma in people aged 12 years and older. FDA Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 16, 2015 Category: Allergy & Immunology Tags: Pulmonary Medicine News Alert Source Type: news
Cardiac Safety of Tiotropium in Patients With Cardiac EventsCardiac Safety of Tiotropium in Patients With Cardiac Events
How safe is the HandiHaler in COPD patients who've had a recent cardiac event? Respiratory Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2015 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news
Olodaterol/tiotropium improves QOL in patients with COPD
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2015 Category: Drugs & Pharmacology Source Type: news
Stiolto Respimat (tiotropium bromide and olodaterol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 13, 2015 Category: Drugs & Pharmacology Source Type: news
Boehringer’s Spiolto Respimat COPD therapy approved in European countries
Boehringer Ingelheim Spiolto Respimat (tiotropium / olodaterol) once-daily maintenance treatment has received regulatory authority approvals in first European countries, to relieve symptoms in adult patients with chronic obstructive pulmonary disease… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 2, 2015 Category: Pharmaceuticals Source Type: news
tiotropium bromide and olodaterol (Stiolto Respimat)
Title: tiotropium bromide and olodaterol (Stiolto Respimat)Category: MedicationsCreated: 7/2/2015 12:00:00 AMLast Editorial Review: 7/2/2015 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 2, 2015 Category: Drugs & Pharmacology Source Type: news
tiotropium bromide and olodaterol (Stiolto Respimat)
Title: tiotropium bromide and olodaterol (Stiolto Respimat)Category: MedicationsCreated: 7/2/2015 12:00:00 AMLast Editorial Review: 7/2/2015 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - July 2, 2015 Category: Respiratory Medicine Source Type: news
Stiolto Respimat (tiotropium bromide and olodaterol) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 5, 2015 Category: Drugs & Pharmacology Source Type: news
Boehringer’s once-daily Stiolto Respimat receives FDA approval for COPD
Boehringer Ingelheim has received approval from the US Food and Drug Administration (FDA) for its once-daily Stiolto Respimat (tiotropium bromide and olodaterol) inhalation spray. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 27, 2015 Category: Pharmaceuticals Source Type: news
